IR@PKUHSC  > 北京大学临床肿瘤学院  > 肿瘤内科
学科主题临床医学
Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors
Yong, WB; Zheng, W; Zhu, J; Zhang, YT; Wei, Y; Wang, XP; Lin, NJ; Xie, Y; Xu, B; Li, JY
关键词midline NK/T-cell lymphoma treatment L-asparaginase prognosis
刊名HEMATOLOGICAL ONCOLOGY
2006-03-01
DOI10.1002/hon.765
24期:1页:28-32
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Hematology
研究领域[WOS]Oncology ; Hematology
关键词[WOS]NATURAL KILLER/T-CELL ; T-CELL ; CLASSIFICATION ; CHEMOTHERAPY ; EXPRESSION ; NEOPLASMS ; RADIATION
英文摘要

Purpose: Midline NK/T-cell lymphoma nasal-type is an aggressive neoplasm with poor prognosis in most instances. To improve the treatment outcome, we have tried using L-asparaginase based regimen as salvage regimen plus radiation in CHOP failures, and report here the therapeutic results and prognostic factors. Patients and methods: From March 1992 to January 2005, 46 Chinese patients with midline NK/T-cell lymphoma nasal-type were initially treated with CHOP regimen as first-line chemotherapy. The patients who failed CHOP regimens were altered to receive L-asparaginase based salvage regimen. All the patients received primary involved-field radiation after chemotherapy. Results: Thirteen patients (28.3%) sensitive to CHOP regimen received CHOP regimen for 6 cycles plus locoregional radiation, and achieved complete remission (CR). Thirty-three patients failed CHOP regimen were altered to received L-asparaginase-based salvage regimen for 2 similar to 6 cycles (median 3 cycles) plus locoregional radiation, and seventeen of the 33 CHOP failures (51.5%) (L-asparaginase group) reached CR. The CR rate for the whole group was 65.2% (30/46 cases). The 5-year overall survival (OS) rates were 64.5% for the whole group and 55.9% for L-asparaginase group, respectively. On univariate analysis, disease stage, fever symptom and performance status were significant factors influencing overall survival. On multivariate analysis, only disease stage and fever symptom remained as independently significant factors influencing OS. Conclusion: In this preliminary study, the results indicated that L-asparaginase based regimen might be a promising new salvage chemotherapeutic regimen in CHOP failures and conduce to improve the treatment outcome in midline NK/T-cell lymphoma, nasal-type. Copyright (c) 2005 John Wiley & Sons, Ltd.

语种英语
WOS记录号WOS:000236408700006
引用统计
被引频次:42[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/60818
专题北京大学临床肿瘤学院_肿瘤内科
作者单位Peking Univ, Beijing Canc Hosp, Sch Oncol, Dept Med Oncol, Beijing 100036, Peoples R China
推荐引用方式
GB/T 7714
Yong, WB,Zheng, W,Zhu, J,et al. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors[J]. HEMATOLOGICAL ONCOLOGY,2006,24(1):28-32.
APA Yong, WB.,Zheng, W.,Zhu, J.,Zhang, YT.,Wei, Y.,...&Li, JY.(2006).Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.HEMATOLOGICAL ONCOLOGY,24(1),28-32.
MLA Yong, WB,et al."Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors".HEMATOLOGICAL ONCOLOGY 24.1(2006):28-32.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yong, WB]的文章
[Zheng, W]的文章
[Zhu, J]的文章
百度学术
百度学术中相似的文章
[Yong, WB]的文章
[Zheng, W]的文章
[Zhu, J]的文章
必应学术
必应学术中相似的文章
[Yong, WB]的文章
[Zheng, W]的文章
[Zhu, J]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。